A Comparative Subjective Assessment Study of PENNSAID® and Voltaren Gel®, Two Topical Formulations of Diclofenac Sodium

Pain Practice

Volumn 11, Issue 3, 2011, Pages 252-260

  Galer, Bradley S ^a  

^a Nuvo Research Inc   (United States)

Author keywords

Diclofenac; DMSO; NSAID; Osteoarthritis; Topical analgesia

Indexed keywords

DICLOFENAC; DIMETHYL SULFOXIDE; PENNSAID; UNCLASSIFIED DRUG; VOLTAREN GEL;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; FEMALE; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; QUESTIONNAIRE;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD;

EID: 79955600261     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2010.00420.x     Document Type: Article

References (18)

1. Grubauer G, Feingold KR, Harris RM, Elias PM. Lipid content and lipid type as determinants of the epidermal permeability barrier. J Lipid Res. 1989;30:89-96.
2. Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS. Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs. 1980;20:24-48.
3. Zacher J, Altman R, Bellamy N, etal. Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin. 2008;24:925-950.
4. ®[Prescribing Information]. Parsippany, NJ: Novartis Consumer Health, Inc.; 2007.
5. Baraf H, Ramsay AJ, Schumacher D, Dreher DS. Long-term safety of diclofenac sodium gel 1% in patients with osteoarthritis of the knee. Osteoarthritis Cartilage. 2007;15:C233.
6. Altman RD, Dreiser RL, Fisher CL, Chase WF, Dreher DS, Zacher J. Diclofenac sodium in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36:1991-1999.
7. Barthel HR, Haselwood D, Longley S 3rd, Gold MS, Altman RD. Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum. 2009;39:203-212.
8. Kienzler JL, Gold M, Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. J Clin Pharmacol. 2010;50:50-61.
9. Kashoki MA. Food and drug administration (center for drug evaluation and research). Supervisory review of NDA 22-122, Voltaren 1% Gel, Novartis, Inc. [WWW document]. URL [accessed on 23 June 2010]. Published October 1, 2007.
10. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56:603-618.
11. ®. [Prescribing Information]. Hazelwood, MO: Mallinckrodt Brand Pharmaceuticals Inc.; 2010.
12. Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med. 2004;164:2017-2023.
13. Baer PA, Thomas LM, Shainhouse Z. Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. BMC Musculoskelet Disord. 2005;6:44.
14. Bookman AA, Williams KS, Shainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ. 2004;171:333-338.
15. Simon LS, Grierson LM, Naseer Z, Bookman AA, Zev Shainhouse J. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain. 2009;143:238-245.
16. ®) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol. 2004;31:2002-2012.
17. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555-567.
18. Say RE, Thomson R. The importance of patient preferences in treatment decisions-challenges for doctors. BMJ. 2003;327:542-545.